NRBO: Total Utang marang Modal NeuroBo Pharmaceuticals, Inc.
NeuroBo Pharmaceuticals (NRBO) management focuses on developing therapeutic agents to combat brain and cardiovascular pathologies. This chart illustrating the total debt-to-equity ratio captured a figure of 0.02. This is driven by a shortage of internal funds due to R&D expenditures, which forces the company to secure loans. The situation is further complicated by strict FDA oversight and patent protection within the metabolic drug sector.
%20-%20Utang%20marang%20Modal&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_NRBO_-_NeuroBo-Pharmaceuticals_-_Debt-to-Capital "Rasio Total Utang marang Ekuitas: NeuroBo Pharmaceuticals (NRBO) kanggo 04.07.2022 - 07.12.2024 | 👁️GURU.Markets👁️")
Rincian metrik lan analitis perusahaan NeuroBo Pharma (NRBO)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas NeuroBo Pharmaceuticals|NRBO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas NeuroBo Pharmaceuticals|NRBO - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku NeuroBo Pharmaceuticals|NRBO - Utang jangka dawa|Kewajiban jangka cendhak perusahaan NeuroBo Pharmaceuticals|Likuiditas cepet neurobopharma.com
- statistik bathi lan rasio pasar:
Analisis umum perusahaan:NeuroBo Pharmaceuticals, Inc., NRBO
Investors use this ratio to assess financial stability and the extent of the company's reliance on borrowed funds. This metric is calculated as the sum of all liabilities divided by equity, and the displayed debt-to-equity ratio is critically important for NeuroBo Pharmaceuticals (NRBO), whose liquidity determines the success of clinical trials for MASH drugs and partnerships with Dong-A ST.
Pesaing NeuroBo Pharmaceuticals
Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Utang marang Ekuitas Harmony Biosciences|Rasio Utang marang Ekuitas BHVN (biohavenpharma.com)|Total Utang marang Modal AMLX|TRVI - Utang marang Modal|Praxis Medicines - Rasio Total Utang marang Ekuitas|Total Utang marang Modal Anavex Life Sciences Corp AVXL|CBLL - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PRTA (Prothena Corporation PLC)|alector.com (ALEC) - Utang marang Ekuitas|Utang marang Modal Annexon Biosciences (ANNX)|OMER (Omeros Corp) - Total Utang marang Modal|Utang marang Ekuitas NGNE|Utang marang Ekuitas AC Immune (ACIU)|VYGR - Utang marang Modal|Neumora Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SCLX|TVGN - Utang marang Ekuitas|Utang Agregat marang Ekuitas ACOG|CGTX: Total Utang marang Modal|inhibikase.com - Rasio Kabeh Utang marang Dana Pribadi|SAVA (Cassava Sciences) - Total Utang marang Modal|Total Utang marang Modal Assertio Therapeutics|Utang marang Ekuitas Coya Therapeutics, Inc. (COYA)|VTGN (vistagen.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Ovid Therapeutics OVID|ABOS - Rasio Total Utang marang Ekuitas|CervoMed - Total Utang marang Modal|ATHE - Total Utang marang Modal|CLNN: Total Utang marang Modal|Rasio Total Utang marang Ekuitas PepGen|JUNS (Jupiter Neurosciences Inc) - Total Utang marang Modal|Utang marang Modal relmada.com RLMD|Rasio Total Utang marang Ekuitas ANVS (Annovis Bio)|Total Utang marang Modal gracetx.com (GRCE)|Firefly Neuroscience Inc - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal KLTO (ANEW Medical)|NeuroSense Therapeutics, Ltd. - Total Utang marang Modal|Koefisien Total Utang marang Modal revivapharma.com RVPH|MTVA: Total Utang marang Modal|Rasio Total Utang marang Ekuitas NeurAxis Inc.|HSDT (Helius Medical Technologies, Inc.) - Total Utang marang Modal|Total Utang marang Modal Passage Bio Corp|Utang marang Ekuitas Neuphoria Therapeutics Inc. (NEUP)|Utang marang Ekuitas NERV (minervaneurosciences.com)|Utang marang Ekuitas Athira Pharma ATHA|Koefisien Total Utang marang Modal Addex Therapeutics Ltd. (ADXN)|ALZN - Utang marang Ekuitas|CYCN (Cyclerion Therapeutics) - Rasio Utang marang Ekuitas|protagenic.com (PTIX) - Utang marang Ekuitas|Pasithea Therapeutics Corp. - Rasio Kabeh Utang marang Dana Pribadi|CRGT (Cortigent Inc) - Total Utang marang Modal|Utang marang Ekuitas ATXI|Utang marang Ekuitas Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA - Utang marang Modal|Utang marang Ekuitas Chromocell Therapeutics CHRO|ELYM: Rasio Utang marang Ekuitas|Intra-Cellular - Total Utang marang Modal|Utang marang Modal Longboard Pharmaceuticals Inc|MRNS (Marinus) - Rasio Total Utang marang Ekuitas|NKGen Biotech Corp (NKGN) - Total Utang marang Modal|Utang marang Ekuitas Sage Therapeutics, Inc.|SNPX: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Trevena (TRVN)|VIGL - Utang marang Modal|Utang marang Ekuitas Anew Medical WENA|CERE: Rasio Utang marang Ekuitas